Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Xuze Pharmaceutical Technology
Beijing, Beijing, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Beijing Xuze Pharmaceutical Technology develops and licenses biomedical products. Its resources include a Phase 4 clinical trial evaluating a carbomer birth canal gel for efficacy and safety in natural delivery, and completion of Phase 1 pharmacokinetic studies for lansoprazole oral formulations in Chinese volunteers. The company is involved in formulation and preparation technology, with at least one patent for injectable oxiracetam solutions.[5][7][9]
- Therapeutic areas
- Women's HealthGastroenterology
- Modalities
- Small moleculePolymer-based topical gel
- Industry
- Biotech
02
Partnerships
Chengdu Innovo Pharmaceutical
Beyond the preview
Go deeper on Beijing Xuze Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Xuze Pharmaceutical Technology.